Siranalen 150 mg tvrde kapsule
Name | Siranalen 150 mg tvrde kapsule |
---|---|
Marketing Authorisation Number | HR-H-758843673 |
Active Substance | pregabalin |
Composition | jedna tvrda kapsula sadrži 150 mg pregabalina |
Pharmaceutical Form | kapsula, tvrda |
Packaging [MA Number for Packaging] | 14 kapsula u blisteru, u kutiji [HR-H-758843673-01] 21 kapsula u blisteru, u kutiji [HR-H-758843673-02] 30 kapsula u blisteru, u kutiji [HR-H-758843673-03] 56 kapsula u blisteru, u kutiji [HR-H-758843673-04] 84 kapsule u blisteru, u kutiji [HR-H-758843673-05] 100 kapsula u blisteru, u kutiji [HR-H-758843673-06] 112 kapsula u blisteru, u kutiji [HR-H-758843673-07] |
Manufacturer | Medochemie Ltd., Limassol, Cipar |
Marketing Authorisation Holder | Medochemie Ltd., Constatinoupoleos Str. 1-10, Limassol, Cipar |
Marketing Authorisation Date | 19.10.2020 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/20-02/93 |
Registration Number | 381-12-01/154-20-02 |
Prescription | na recept |
Type of prescription | ponovljivi recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | N02BF02 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | download |